CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients
DOI 10.1055/a-2284-0593
Bibliografische Angaben
Nachweis in CareLit
Autor:innenLaura Schubert, Hannes Rennau, Jens Kurth, Bernd J. Krause, Guido Hildebrandt, Sarah Marie Schwarzenböck
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe03/2024
Jahrgang / SeitenJg. 63 · S. 199-206
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Aim This study aimed to assess the impact of 68Ga-PSMA PET/CT on radiation treatment (RT) planning in prostate cancer patients with salvage (sRT) or definitive (dRT) radiotherapy. Methods 38 patients (27 sRT, median PSA 0.79 ng/ml (range 0.06–12.1); 11 dRT, median PSA 4.35 ng/ml (range 1.55–55.5) underwent 68Ga-PSMA PET/CT before RT. Influence of 68Ga-PSMA PET/CT on the extent of planning target volume (PTV…
Zitieren
Zitierempfehlung
Laura Schubert, Hannes Rennau, Jens Kurth, Bernd J. Krause, Guido Hildebrandt, Sarah Marie Schwarzenböck (2024) Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients. Nuklearmedizin - NuclearMedicine, 63 (03), 199-206. https://doi.org/10.1055/a-2284-0593
Mit CareLit weiterarbeiten